Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
28 June 2022 | Story Rulanzen Martin | Photo Sonia Small (Kaleidoscope Studios)
Dr Munyaradzi Mushonga is very optimistic about his appointment as the Global Academic Director of the Decolonial International Network.

Dr Munyaradzi Mushonga of the Centre for Gender and Africa Studies (CGAS) at the University of the Free State (UFS) has been appointed Global Academic Director of the Decolonial International Network (DIN). Dr Mushonga, who is a senior lecturer and programme director of CGAS’s Africa Studies programme, says his vision for DIN is “to work towards a new world civilisation that is opposed to the militarism and war, lawlessness and genocides of other civilisations.” 

Dr Mushonga, who is a leading voice and scholar on decolonialisation, will formally assume his role at DIN in 2023. 

The duality of new technology and scholarly work

Dr Mushonga says it is important for our minds to be decolonised, and he is therefore planning to establish a Centre for Decolonising The Mind (CDTM), which will use 21st-century technologies to achieve the ideal of decolonialisation. “Here pluriversal decolonial chapters and centres will be driven towards developing a decolonial history app,” he says. The aim is also to work towards a decolonial textbook on the history of Africa. 

He says it is commendable to employ technology to address decolonisation, but the real work to achieve the ideal of a decolonial mind lies in the scholarly work done by academics. At the CGAS the entire Africa Studies programme addresses decolonial theory and praxis through several approaches. “These are informed by our identity, which is anchored on two pillars, namely the interdisciplinary nature of all our engagements, as well as the exploration and critique of what it means to be ‘human’, but also in relation to the ‘non-human’ world.” He adds that the Centre’s teaching, supervision, and engagement with its students also challenges academics to think beyond the binaries of ‘coloniser’ and ‘colonised’, ‘white’ and ‘black’, and to reject all forms of fundamentalism. 

UFS’s commitment to decoloniality is a great asset 

Dr Mushonga's tenure at DIN will also reinforce the commitment to decolonial education made by the UFS, which has been noted by DIN. “I am convinced that DIN, the CGAS and the UFS can become the great vehicles to drive the decolonial agenda from the global South in general, and South Africa in particular,” he says. He says the commitment to the ideals of decolonisation displayed by UFS and the CGAS played a large part in his appointment to his new DIN role. 

The CGAS and the UFS will become key players in the DIN project, and Dr Mushonga hopes that more individuals and groups will come forward to join forces with DIN. “I hope this will enable DIN to push for new ethics in living.” 

News Archive

Nano research at the UFS opens door to smart drugs
2011-06-27

 

Prof. Lodewyk Kock, outstanding professor in our Department of Microbial, Biochemical and Food Biotechnology

Novel antifungal, anticancer and anti-malaria drugs that have been identified in the research of Prof. Lodewyk Kock, outstanding professor in the Department of Microbial, Biochemical and Food Biotechnology at our university, will be disclosed later this year at major international conferences in Asia, Europe and the USA. Prof. Kock will be the keynote speaker at these conferences. 

His presentations will be based on the department’s discovery of yeast assays linked to a new nanotechnology for medicine. The assays were recently discovered by his group and can be applied in the development of novel antifungal, anticancer and anti-malaria drugs.
 
Prof. Kock’s focused research at the university, which now also includes his novel nanotechnology for Biology, began in 1982 in collaboration with Prof. Pieter van Wyk (Centre for Microscopy). He recently collaborated with Prof. Hendrik Swart (Department of Physics).
 
Prof. Kock says the development of novel anti-malaria drugs in particular is getting attention across the world due to the high rates of morbidity and mortality caused by the disease worldwide. Approximately 225 million people are infected annually and about a million (many in Africa) die each year. “Many potential smart drugs have been identified with this research and should now be tested further,” says Kock.
  
These new drugs will be disclosed during Prof. Kock’s keynote addresses at the International Conference and Exhibition on Pharmaceutical Regulatory Affairs in Baltimore, USA, from 6 to 7 September 2011, the Medichem 2011 in Beijing, China from 9 to 11 August 2011 and the XVI Congress of European Mycologists in Greece, from 19 to 23 September 2011.

 

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept